Navigation Links
Synthetic Biology: Coming Up Fast!
Date:10/27/2008

WASHINGTON Synthetic biology is being touted by scientists and venture capitalists as "the next big thing." Researchers claim to be on the brink of creating artificial life in a laboratory and making the world's first synthetic microbes. The first blockbuster synbio drugan affordable cure for malariais expected on the market by 2010. And a whole new biofuels industry spawned by synthetic biologists that promises to conquer the globe's energy problems seems just around the corner.

But will the promises and pitfalls of synthetic biology catch governments, ethicists, biosafety and biosecurity experts, and the public by surprise? Denise Caruso, former New York Times columnist and longtime analyst of technology-based issues and industries, will explore this question with the Center for American Progress's Rick Weiss. Caruso is the author of Intervention: Confronting the Real Risks of Genetic Engineering and Life on a Biotech Planet (2006). Weiss recently left The Washington Post after a distinguished career as one of the country's foremost science journalists.

Synthetic biology is an emerging area of research that uses advanced science and engineering to make or redesign living organisms, such as bacteria, so that they can carry out specific functions. The Rathenau Instituut describes the field as the convergence of molecular biology, information technology and nanotechnology, leading to the systematic design of biological systems.

This program is being jointly sponsored by the Project on Emerging Nanotechnologies and the Center for American Progress.

To attend the event, RSVP to nano@wilsoncenter.org. No RSVP is required to view the Web cast.

*** Webcast LIVE at www.wilsoncenter.org ***

What: Synthetic Biology: Coming Up Fast!

When: Friday, November 14, 2008, 12:30 1:30 PM (Light lunch available in 6th Floor Board Room prior to the event at 11:45 a.m.)

Who: Denise Caruso, Executive Director & Chair, Hybrid Vigor Institute
Rick Weiss, Senior Fellow, Center for American Progress, Moderator
David Rejeski, Director, Project on Emerging Nanotechnologies, Introduction

Where: Woodrow Wilson International Center for Scholars, 6th Floor Auditorium, in the Ronald Reagan Building at 1300 Pennsylvania Avenue, NW, Washington, DC. For directions see: http://www.wilsoncenter.org/directions


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
2. New synthetic form of protein holds promise to stop cancer spread
3. Synthetic moleculues could add spice to fight against cancer
4. Synthetic molecules emulate enzyme behavior for the first time
5. Synthetic cocoa chemical slows growth of tumors in human cell lines
6. Synthetic Biology: funders move to address social and ethical challenges
7. New projects to raise UK profile in synthetic biology
8. Oregano oil works as well as synthetic insecticides to tackle common beetle pest
9. Berkeley researchers identify photosynthetic dimmer switch
10. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
11. Researchers decode genetics of rare photosynthetic bacterium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... January 12, 2017 A new report by Allied Market Research, ... global biometric technology market is expected to generate revenue of $10.72 billion by 2022, ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In ...
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is proud ... 21 CFR Part 11-compliant email client designed to provide product vigilance departments with ...
Breaking Biology Technology: